Synthesis and biological analysis of a new curcumin analogue for enhanced anti-tumor activity in HepG 2 cells

Oncology Reports

Volumn 23, Issue 5, 2010, Pages 1435-1441

  Xiao, Jian ^a   Chu, Yanhui ^b   Hu, Keqiong ^a   Wan, Jin ^a   Huang, Yi ^a   Jiang, Chengxi ^a   Liang, Guang ^a   Li, Xiaokun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Curcumin analogue; Endoplasmic reticulum stress

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ANTINEOPLASTIC AGENT; CALCIUM; CASPASE 3; CURCUMIN; FLUORESCENT DYE; FURA 2 ACETOXYMETHYL ESTER; GL 63; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; BROMOBENZENES; CALCIUM; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL SURVIVAL; CURCUMIN; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; HEAT-SHOCK PROTEINS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PENTANONES; RATS; STRESS, PHYSIOLOGICAL; TIME FACTORS; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS;

EID: 77950800699     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000781     Document Type: Article

References (29)

1. Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang JF, Zhu M, Chen JC, Chen CS, Duan X, Klag MJ and He J: Mortality attributable to smoking in China. N Engl J Med 360: 150-159, 2009.
2. Lev-Ari S, Lichtenberg D and Arber N: Compositions for treatment of cancer and inflammation. Recent Pat Anticancer Drug Discov 3: 55-62, 2008.
3. Strimpakos AS and Sharma RA: Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10: 511-545, 2008.
4. Hatcher H, Planalp R, Cho J, Torti FM and Torti SV: Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65: 1631-1652, 2008.
5. Freudlsperger C, Greten J and Schumacher U: Curcumin induces apoptosis in human neuroblastoma cells via inhibition of nfkappab. Anticancer Res 28: 209-214, 2008.
6. Javvadi P, Segan AT, Tuttle SW and Koumenis C: The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 73: 1491-1501, 2008.
7. Subramaniam D, May R, Sureban SM, Lee KB, George R, Kuppusamy P, Ramanujam RP, Hideg K, Dieckgraefe BK, Houchen CW and Anant S: Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Res 68: 1962-1969, 2008.
8. Pae HO, Jeong SO, Jeong GS, Kim KM, Kim HS, Kim SA, Kim YC, Kang SD, Kim BN and Chung HT: Curcumin induces pro-apoptotic endoplasmic reticulum stress in human leukemia hl-60 cells. Biochem Biophys Res Commun 353: 1040-1045, 2007.
9. Anand P, Kunnumakkara AB, Newman RA and Aggarwal BB: Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818, 2007.
10. Appiah-Opong R, de Esch I, Commandeur JN, Andarini M and Vermeulen NP: Structure-activity relationships for the inhibition of recombinant human cytochromes p450 by curcumin analogues. Eur J Med Chem 43: 1621-1631, 2008.
11. Sharma RA, Steward WP and Gescher AJ: Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595: 453-470, 2007.
12. Wang X, Lin J, Chen Y, Zhong W, Zhao G, Liu H, Li S, Wang L and Li S: Novel fatty acid synthase (fas) inhibitors: design, synthesis, biological evaluation, and molecular docking studies. Bioorg Med Chem 17: 1898-1904, 2009.
13. Selvam C, Jachak SM, Thilagavathi R and Chakraborti AK: Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents. Bioorg Med Chem Lett 15: 1793-1797, 2005.
14. Ohori H, Yamakoshi H, Tomizawa M, Shibuya M, Kakudo Y, Takahashi A, Takahashi S, Kato S, Suzuki T, Ishioka C, Iwabuchi Y and Shibata H: Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol Cancer Ther 5: 2563-2571, 2006.
15. Mosley CA, Liotta DC and Snyder JP: Highly active anticancer curcumin analogues. Adv Exp Med Biol 595: 77-103, 2007.
16. Liang G, Li X, Chen L, Yang S, Wu X, Studer E, Gurley E, Hylemon PB, Ye F, Li Y and Zhou H: Synthesis and antiinflammatory activities of mono-carbonyl analogues of curcumin. Bioorg Med Chem Lett 18: 1525-1529, 2008. (Pubitemid 351226515)
17. Liang G, Yang SL, Shao LL, Zhao CG, Xiao J, Lv YX, Yang J, Zhao Y and Li XK: Synthesis, structure, and bioevaluation of 2, 5-bis(arylmethenyl) cyclopentanones. J Asian Nat Prod Res 10: 957-965, 2008.
18. Liang G, Yang S, Zhou H, Shao L, Huang K, Xiao J, Huang Z and Li X: Synthesis, crystal structure and anti-inflammatory properties of curcumin analogues. Eur J Med Chem 44: 915-919, 2009.
19. Liang G, Yang S, Jiang L, Zhao Y, Shao L, Xiao J, Ye F, Li Y and Li X: Synthesis and anti-bacterial properties of monocarbonyl analogues of curcumin. Chem Pharm Bull (Tokyo) 56: 162-167, 2008. (Pubitemid 351206638)
20. Liang G, Shao L, Wang Y, Zhao C, Chu Y, Xiao J, Zhao Y, Li X and Yang S: Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. Bioorg Med Chem 17: 2623-2631, 2009.
21. Sun A, Shoji M, Lu YJ, Liotta DC and Snyder JP: Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system. J Med Chem 49: 3153-3158, 2006.
22. Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, Sun A, Snyder JP, Liotta DC, Jones DP and Shoji M: EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs 16: 263-275, 2005.
23. Pae HO, Jeong SO, Kim HS, Kim SH, Song YS, Kim SK, Chai KY and Chung HT: Dimethoxycurcumin, a synthetic curcumin analogue with higher metabolic stability, inhibits no production, inducible no synthase expression and NF-kappaB activation in raw264.7 macrophages activated with lPS. Mol Nutr Food Res 52: 1082-1091, 2008.
24. Zou W, Yue P, Khuri FR and Sun SY: Coupling of endoplasmic reticulum stress to CDDO-me-induced up-regulation of death receptor 5 via a chop-dependent mechanism involving JNK activation. Cancer Res 68: 7484-7492, 2008.
25. Zhang K and Kaufman RJ: Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 279: 25935-25938, 2004. (Pubitemid 38798732)
26. Oyadomari S and Mori M: Roles of chop/gadd153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-389, 2004.
27. Bakhshi J, Weinstein L, Poksay KS, Nishinaga B, Bredesen DE and Rao RV: Coupling endoplasmic reticulum stress to the cell death program in mouse melanoma cells: effect of curcumin. Apoptosis 13: 904-914, 2008.
28. Lin SS, Huang HP, Yang JS, Wu JY, Hsia TC, Lin CC, Lin CW, Kuo CL, Gibson Wood W and Chung JG: DNA damage and endoplasmic reticulum stress mediated curcumininduced cell cycle arrest and apoptosis in human lung carcinoma A549 cells through the activation of caspases cascade- and mitochondrial-dependent pathway. Cancer Lett 272: 77-90, 2008.
29. Yamaguchi H and Wang HG: Chop is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem 279: 45495- 45502, 2004.